Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
100 studies found for:    "Inflammatory breast cancer"
Show Display Options
Rank Status Study
1 Recruiting Case-Control Study of Inflammatory Breast Cancer in North Africa
Condition: Inflammatory Breast Cancer
Intervention:
2 Recruiting Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer
Condition: Inflammatory Breast Cancer
Interventions: Biological: Bevacizumab;   Drug: Cyclophosphamide;   Drug: epirubicin hydrochloride;   Drug: fluorouracil;   Drug: Docetaxel;   Biological: Trastuzumab
3 Completed Establishing an Inflammatory Breast Cancer Registry
Condition: Inflammatory Breast Cancer
Intervention:
4 Completed Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia
Condition: Inflammatory Breast Cancer
Intervention:
5 Not yet recruiting Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
Condition: Inflammatory Breast Cancer (IBC).
Interventions: Drug: Ruxolitinib;   Drug: Paclitaxel;   Drug: Doxorubicin;   Drug: Cyclophosphamide
6 Completed Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer
Condition: Inflammatory Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Cyclophosphamide;   Drug: Epirubicin
7 Recruiting A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer
Conditions: Inflammatory Breast Cancer;   Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Interventions: Drug: Eribulin;   Drug: Adriamycin;   Drug: Cyclophosphamide
8 Recruiting Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy
Condition: Inflammatory Breast Carcinoma
Interventions: Drug: 89Zr-bevacizumab;   Procedure: FDG-PET/CT;   Procedure: MRI scan;   Procedure: Tumor biopsies
9 Not yet recruiting A Study of Anti-PD-1 (Pembrolizumab) + Hormonal Therapy in HR-positive Localized IBC Patients With Non-pCR to Neoadjuvant Chemotherapy
Conditions: Inflammatory Breast Cancer;   Malignant Neoplasm of Breast
Intervention: Drug: Pembrolizumab
10 Not yet recruiting Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer
Conditions: HER2/Neu Negative;   Recurrent Inflammatory Breast Carcinoma;   Stage IV Breast Cancer;   Stage IV Inflammatory Breast Carcinoma
Interventions: Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab
11 Suspended Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer
Conditions: HER2-negative Breast Cancer;   Inflammatory Breast Cancer;   Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: Romidepsin;   Drug: Abraxane
12 Recruiting Inflammatory Breast Cancer (IBC) Registry
Condition: Breast Cancer
Interventions: Other: Interview;   Procedure: Blood and Tissue Collection
13 Completed Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer
Condition: Breast Cancer
Interventions: Biological: pegfilgrastim;   Drug: docetaxel;   Drug: epirubicin hydrochloride
14 Completed Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer
Condition: Neoplasms, Breast
Intervention: Drug: lapatinib
15 Completed TKI258 for Metastatic Inflammatory Breast Cancer Patients
Condition: Breast Cancer
Intervention: Drug: Dovitinib
16 Recruiting MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer
Condition: Breast Cancer
Intervention:
17 Completed Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis
Condition: Breast Neoplasms
Intervention:
18 Terminated
Has Results
Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer
Condition: Breast Cancer
Interventions: Biological: herceptin;   Drug: carboplatin;   Drug: docetaxel;   Procedure: conventional surgery;   Procedure: radiation therapy
19 Completed SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer
Condition: Breast Cancer
Interventions: Drug: doxorubicin hydrochloride;   Drug: semaxanib;   Procedure: conventional surgery;   Radiation: radiation therapy;   Drug: tamoxifen
20 Terminated
Has Results
Phase II Neoadjuvant in Inflammatory Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Lapatinib;   Drug: Paclitaxel;   Drug: 5-Fluorouracil (5-FU);   Drug: Epirubicin;   Drug: Cyclophosphamide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.